HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Successful conservative treatment of coecal perforation in a patient with Ogilvie's syndrome].

Abstract
The case report describes a 37-year-old woman who was diagnosed with Ogilvie's syndrome after caesarean section. Conservative treatment was initiated with minimal effect, and the patient was subsequently treated with IV neostigmine. A computed tomography of the abdomen revealed enlarged peritoneal cavity. However the patient was clinically unaffected without fever or signs of peritonitis. The perforation was managed with a conservative approach including antibiotics and close observation of the patient. After nine days the patient was discharged with normal gastrointestinal function and without further reported complications.
AuthorsChristian Lyngsaa Lang, Maria Cecilie Haveman, Michael Achiam
JournalUgeskrift for laeger (Ugeskr Laeger) Vol. 175 Issue 16 Pg. 1120-1 (Apr 15 2013) ISSN: 1603-6824 [Electronic] Denmark
Vernacular TitleVellykket konservativt behandlet caecumperforation ved Ogilvies syndrom.
PMID23651754 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Parasympathomimetics
  • Neostigmine
Topics
  • Adult
  • Anti-Bacterial Agents (therapeutic use)
  • Cecal Diseases (diagnostic imaging, drug therapy, etiology, therapy)
  • Cesarean Section
  • Colonic Pseudo-Obstruction (complications, diagnostic imaging, drug therapy, therapy)
  • Female
  • Humans
  • Intestinal Perforation (diagnostic imaging, drug therapy, etiology, therapy)
  • Neostigmine (administration & dosage, therapeutic use)
  • Parasympathomimetics (administration & dosage, therapeutic use)
  • Pregnancy
  • Radiography
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: